New CDMO site introducing the most advanced and large-scale single-use bioreactors in Japan Today, we announced a strategic decision about the large-scale single-use technology it will use at its new Yokohama, Japan facility. The CDMO is introducing two 5,000 L Thermo Scientific DynaDrive Single-Use Bioreactors (S.U.B.), which makes the site one of the most advanced […]
BICO Group AB (“BICO”) has entered into an agreement to divest MatTek Corp (“MatTek”) and Visikol Inc (“Visikol”) to Sartorius Lab Holding GmbH (“Sartorius”) for USD 80m, on a cash and debt-free basis. The divestment follows the Group’s updated strategy with focus on lab automation and selected workflows. The proceeds from the transaction will be […]
Acquisition will advance Sartorius’ cell culture portfolio with 3D microtissue models and primary cells MatTek’s solutions are highly compatible with Sartorius’ cell analysis instruments, reagents and AI models for faster and more effective drug development Göttingen, Germany — The life science group Sartorius has agreed to acquire MatTek Corp, including Visikol Inc, from BICO Group […]
HATFIELD, Pa. — Biolyst Scientific, a leading provider of innovative solutions in the life sciences and clinical laboratory markets, is pleased to announce the appointment of Jay Hexamer as its new Chief Executive Officer (CEO), effective immediately. This leadership transition reflects Biolyst Scientific’s continued focus on innovation and market expansion. With more than 30 years of experience in […]
Settlement Supports Vizgen’s Continued Commercialization and Ongoing Development of Transformative MERFISH Technology CAMBRIDGE, Mass. — Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today released an open letter in response to the settlement of litigation between Vizgen, Harvard University and 10X Genomics in the United States District […]
Scale Bio’s QuantumScale Single Cell RNA Kits Are Now Available for Order to Commercial and Academic Customers, Enabling the Analysis of Millions of Cells in a Single Workflow San Diego, Calif. – Scale Biosciences, Inc. (Scale Bio), a leader in highly scalable single cell technologies, today announced its participation in the Chan Zuckerberg Initiative’s (CZI) Billion […]
Pioneer Group is pleased to announce that we have entered into a strategic partnership with Miltenyi Biotec, an innovator of products and services for biomedical research and cell and gene therapies. Through this collaboration, Miltenyi Biotec will establish a suite of state-of-the-art instruments at Victoria House, our flagship life sciences centre in London’s Knowledge Quarter. This strategic […]
New Partnership Brings Innovative Single Cell Solutions to Researchers Across Japan SEATTLE — Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Tokyo-based SCRUM Inc. to expand its presence in Japan’s research community. This collaboration will provide researchers in academia and industry with full access to Parse’s […]
Akoya’s technology to generate data for a first-of-its-kind Biobank and Data Repository for Cancer Equity Research, funded through the Cancer Grand Challenges initiative The unprecedented scale of the initiative requires the high plex and high throughput of Akoya’s PhenoCycler-Fusion platform to process thousands of patients’ samples MARLBOROUGH, Mass. — Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial […]
Stratyx™ 250 is an innovative new bioreactor system from Culture Biosciences that accelerates bioprocess development, reduces costs and provides real-time remote control and monitoring for teams working on applications ranging from cell line development to protein expression. SOUTH SAN FRANCISCO, Calif. — Culture Biosciences, a leader in cloud-based biomanufacturing, announced the launch of Stratyx™ 250, the first […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
